MN-25

CAS No. 501926-82-5

MN-25( MN 25 | AR-12 | AR 12 )

Catalog No. M14692 CAS No. 501926-82-5

A potent, reasonably selective agonist of peripheral cannabinoid receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MN-25
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, reasonably selective agonist of peripheral cannabinoid receptor.
  • Description
    A potent, reasonably selective agonist of peripheral cannabinoid receptor with Ki of 11 nM for CB2, 22-fold selectivity over the psychoactive CB1 receptors (Ki=245 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MN 25 | AR-12 | AR 12
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    501926-82-5
  • Formula Weight
    439.59
  • Molecular Formula
    C26H37N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(C2CCC(C2)(C1NC(=O)C3=CN(C4=C3C=CC=C4OC)CCN5CCOCC5)C)C
  • Chemical Name
    N-[(S)-Fenchyl]-1-[2-(morpholin-4-yl)ethyl]-7-methoxyindole-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wrobleski ST, et al. J Med Chem. 2003 May 22;46(11):2110-6. 2. Hynes J Jr, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2399-402.
molnova catalog
related products
  • LY2828360

    LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100000 nM respectively).

  • CB 65

    CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.

  • CB2R/FAAH modulator-...

    CB2R/FAAH modulator-3 (compound 27) is a modulator targeting CB2R and FAAH, acting as a CB2R agonist with a Ki value of 20.1 nM and a CB1R agonist with a Ki value of 67.6 nM, while inhibiting FAAH with an IC50 value of 3.4 μM.